Gastroesophageal Reflux in Infants Treatments
Find Gastroesophageal Reflux in Infants Treatments
Medications for Gastroesophageal Reflux in Infants
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Gastroesophageal Reflux in Infants.
Found 1 Approved Drug for Gastroesophageal Reflux in Infants
Metoclopramide
Brand Names
Gimoti, Reglan
Metoclopramide
Brand Names
Gimoti, Reglan
Form: Injection, Spray, Tablet, Solution
Method of administration: Nasal, Oral, Intravenous, Intramuscular
FDA approval date: September 30, 1990
Classification: Dopamine-2 Receptor Antagonist
GIMOTI is indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. GIMOTI is a dopamine-2 (D 2 ) antagonist indicated for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis. ( 1 ) Limitations of Use : GIMOTI is not recommended for use in: pediatric patients due to the risk of tardive dyskinesia (TD) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates. ( 1.
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances